ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care Diagnostics (POCD) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Othe-2Z478
Home | Market Reports | Health| Medical Facilities & Services
Point of Care Diagnostics Market
BUY CHAPTERS

Global Point of Care Diagnostics (POCD) Market Research Report 2025

Code: QYRE-Othe-2Z478
Report
September 2025
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer HealthCare
Beckman Coulter
Nipro Diagnostics
Bio Rad Laboratories
Nova Biomedical
Biomerieux
Quidel
Helena Laboratories
Orasure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Instrumentation Laboratory
Alere Inc
Qiagen NV

Point of Care Diagnostics (POCD) Market Size

The global market for Point of Care Diagnostics (POCD) was valued at US$ 27740 million in the year 2024 and is projected to reach a revised size of US$ 37340 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Point of Care Diagnostics (POCD) Market

Point of Care Diagnostics (POCD) Market

Point of care tests, also called near-patient testing or bedside testing, refers to the performance of diagnostic tests at or near the site where the patient is located and helps in obtaining accurate results in a very short period of time.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Point of Care Diagnostics (POCD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Diagnostics (POCD).
The Point of Care Diagnostics (POCD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care Diagnostics (POCD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Diagnostics (POCD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Point of Care Diagnostics (POCD) Market Report

Report Metric Details
Report Name Point of Care Diagnostics (POCD) Market
Accounted market size in year US$ 27740 million
Forecasted market size in 2031 US$ 37340 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Tumor Markers Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Others
Segment by Application
  • Clinics
  • Hospitals
  • Assisted Living Healthcare Facilities
  • Laboratory
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech, Instrumentation Laboratory, Sekisui Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Point of Care Diagnostics (POCD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Point of Care Diagnostics (POCD) Market growing?

Ans: The Point of Care Diagnostics (POCD) Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Point of Care Diagnostics (POCD) Market size in 2031?

Ans: The Point of Care Diagnostics (POCD) Market size in 2031 will be US$ 37340 million.

Who are the main players in the Point of Care Diagnostics (POCD) Market report?

Ans: The main players in the Point of Care Diagnostics (POCD) Market are Alere, Roche, Abbott Laboratories, Johnson & Johnson, Siemens Healthcare, Danaher, QIAGEN, Bayer Healthcare, Beckman Coulter, Nipro Diagnostics, Bio-Rad Laboratories, Nova Biomedical, BioMerieux, Quidel, Helena Laboratories, OraSure Technologies, Accriva, Abaxis, Chembio Diagnostics, Trinity Biotech, Instrumentation Laboratory, Sekisui Diagnostics

What are the Application segmentation covered in the Point of Care Diagnostics (POCD) Market report?

Ans: The Applications covered in the Point of Care Diagnostics (POCD) Market report are Clinics, Hospitals, Assisted Living Healthcare Facilities, Laboratory

What are the Type segmentation covered in the Point of Care Diagnostics (POCD) Market report?

Ans: The Types covered in the Point of Care Diagnostics (POCD) Market report are Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy and Fertility Testing, Blood Gas/Electrolytes Testing, Tumor Markers Testing, Urinalysis Testing, Cholesterol Testing, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2020-2031)
2.2 Global Point of Care Diagnostics (POCD) Growth Trends by Region
2.2.1 Global Point of Care Diagnostics (POCD) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Point of Care Diagnostics (POCD) Historic Market Size by Region (2020-2025)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2026-2031)
2.3 Point of Care Diagnostics (POCD) Market Dynamics
2.3.1 Point of Care Diagnostics (POCD) Industry Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2020-2025)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2020-2025)
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2024
3.5 Global Key Players of Point of Care Diagnostics (POCD) Head office and Area Served
3.6 Global Key Players of Point of Care Diagnostics (POCD), Product and Application
3.7 Global Key Players of Point of Care Diagnostics (POCD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2020-2025)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2026-2031)
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2020-2025)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2020-2031)
6.2 North America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Point of Care Diagnostics (POCD) Market Size by Country (2020-2025)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2020-2031)
7.2 Europe Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Country (2020-2025)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2020-2031)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2020-2025)
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2020-2031)
9.2 Latin America Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2020-2025)
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2020-2031)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2020-2025)
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Details
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Details
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Details
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Details
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Details
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Details
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Details
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Details
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Details
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Details
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Details
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.18.5 Abaxis Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Details
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
11.19.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.19.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Details
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Details
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Details
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025)
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Roche
Abbott Laboratories
Johnson & Johnson
Siemens Healthcare
Danaher
Bayer HealthCare
Beckman Coulter
Nipro Diagnostics
Bio Rad Laboratories
Nova Biomedical
Biomerieux
Quidel
Helena Laboratories
Orasure Technologies
Accriva
Abaxis
Chembio Diagnostics
Trinity Biotech
Sekisui Diagnostics
Instrumentation Laboratory
Alere Inc
Qiagen NV
List of Tables
 Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood Glucose Testing
 Table 3. Key Players of Infectious Diseases Testing
 Table 4. Key Players of Cardiac Markers Testing
 Table 5. Key Players of Coagulation Testing
 Table 6. Key Players of Pregnancy and Fertility Testing
 Table 7. Key Players of Blood Gas/Electrolytes Testing
 Table 8. Key Players of Tumor Markers Testing
 Table 9. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Point of Care Diagnostics (POCD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Point of Care Diagnostics (POCD) Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Point of Care Diagnostics (POCD) Market Share by Region (2020-2025)
 Table 13. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Point of Care Diagnostics (POCD) Market Share by Region (2026-2031)
 Table 15. Point of Care Diagnostics (POCD) Market Trends
 Table 16. Point of Care Diagnostics (POCD) Market Drivers
 Table 17. Point of Care Diagnostics (POCD) Market Challenges
 Table 18. Point of Care Diagnostics (POCD) Market Restraints
 Table 19. Global Point of Care Diagnostics (POCD) Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Point of Care Diagnostics (POCD) Market Share by Players (2020-2025)
 Table 21. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2024)
 Table 22. Ranking of Global Top Point of Care Diagnostics (POCD) Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Point of Care Diagnostics (POCD) Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Point of Care Diagnostics (POCD), Headquarters and Area Served
 Table 25. Global Key Players of Point of Care Diagnostics (POCD), Product and Application
 Table 26. Global Key Players of Point of Care Diagnostics (POCD), Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Point of Care Diagnostics (POCD) Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2020-2025)
 Table 30. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2026-2031)
 Table 32. Global Point of Care Diagnostics (POCD) Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2020-2025)
 Table 34. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2026-2031)
 Table 36. North America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Point of Care Diagnostics (POCD) Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Point of Care Diagnostics (POCD) Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Point of Care Diagnostics (POCD) Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Point of Care Diagnostics (POCD) Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Point of Care Diagnostics (POCD) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Point of Care Diagnostics (POCD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Alere Company Details
 Table 52. Alere Business Overview
 Table 53. Alere Point of Care Diagnostics (POCD) Product
 Table 54. Alere Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 55. Alere Recent Development
 Table 56. Roche Company Details
 Table 57. Roche Business Overview
 Table 58. Roche Point of Care Diagnostics (POCD) Product
 Table 59. Roche Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 60. Roche Recent Development
 Table 61. Abbott Laboratories Company Details
 Table 62. Abbott Laboratories Business Overview
 Table 63. Abbott Laboratories Point of Care Diagnostics (POCD) Product
 Table 64. Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 65. Abbott Laboratories Recent Development
 Table 66. Johnson & Johnson Company Details
 Table 67. Johnson & Johnson Business Overview
 Table 68. Johnson & Johnson Point of Care Diagnostics (POCD) Product
 Table 69. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 70. Johnson & Johnson Recent Development
 Table 71. Siemens Healthcare Company Details
 Table 72. Siemens Healthcare Business Overview
 Table 73. Siemens Healthcare Point of Care Diagnostics (POCD) Product
 Table 74. Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 75. Siemens Healthcare Recent Development
 Table 76. Danaher Company Details
 Table 77. Danaher Business Overview
 Table 78. Danaher Point of Care Diagnostics (POCD) Product
 Table 79. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 80. Danaher Recent Development
 Table 81. QIAGEN Company Details
 Table 82. QIAGEN Business Overview
 Table 83. QIAGEN Point of Care Diagnostics (POCD) Product
 Table 84. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 85. QIAGEN Recent Development
 Table 86. Bayer Healthcare Company Details
 Table 87. Bayer Healthcare Business Overview
 Table 88. Bayer Healthcare Point of Care Diagnostics (POCD) Product
 Table 89. Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 90. Bayer Healthcare Recent Development
 Table 91. Beckman Coulter Company Details
 Table 92. Beckman Coulter Business Overview
 Table 93. Beckman Coulter Point of Care Diagnostics (POCD) Product
 Table 94. Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 95. Beckman Coulter Recent Development
 Table 96. Nipro Diagnostics Company Details
 Table 97. Nipro Diagnostics Business Overview
 Table 98. Nipro Diagnostics Point of Care Diagnostics (POCD) Product
 Table 99. Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 100. Nipro Diagnostics Recent Development
 Table 101. Bio-Rad Laboratories Company Details
 Table 102. Bio-Rad Laboratories Business Overview
 Table 103. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product
 Table 104. Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 105. Bio-Rad Laboratories Recent Development
 Table 106. Nova Biomedical Company Details
 Table 107. Nova Biomedical Business Overview
 Table 108. Nova Biomedical Point of Care Diagnostics (POCD) Product
 Table 109. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 110. Nova Biomedical Recent Development
 Table 111. BioMerieux Company Details
 Table 112. BioMerieux Business Overview
 Table 113. BioMerieux Point of Care Diagnostics (POCD) Product
 Table 114. BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 115. BioMerieux Recent Development
 Table 116. Quidel Company Details
 Table 117. Quidel Business Overview
 Table 118. Quidel Point of Care Diagnostics (POCD) Product
 Table 119. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 120. Quidel Recent Development
 Table 121. Helena Laboratories Company Details
 Table 122. Helena Laboratories Business Overview
 Table 123. Helena Laboratories Point of Care Diagnostics (POCD) Product
 Table 124. Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 125. Helena Laboratories Recent Development
 Table 126. OraSure Technologies Company Details
 Table 127. OraSure Technologies Business Overview
 Table 128. OraSure Technologies Point of Care Diagnostics (POCD) Product
 Table 129. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 130. OraSure Technologies Recent Development
 Table 131. Accriva Company Details
 Table 132. Accriva Business Overview
 Table 133. Accriva Point of Care Diagnostics (POCD) Product
 Table 134. Accriva Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 135. Accriva Recent Development
 Table 136. Abaxis Company Details
 Table 137. Abaxis Business Overview
 Table 138. Abaxis Point of Care Diagnostics (POCD) Product
 Table 139. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 140. Abaxis Recent Development
 Table 141. Chembio Diagnostics Company Details
 Table 142. Chembio Diagnostics Business Overview
 Table 143. Chembio Diagnostics Point of Care Diagnostics (POCD) Product
 Table 144. Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 145. Chembio Diagnostics Recent Development
 Table 146. Trinity Biotech Company Details
 Table 147. Trinity Biotech Business Overview
 Table 148. Trinity Biotech Point of Care Diagnostics (POCD) Product
 Table 149. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 150. Trinity Biotech Recent Development
 Table 151. Instrumentation Laboratory Company Details
 Table 152. Instrumentation Laboratory Business Overview
 Table 153. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product
 Table 154. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 155. Instrumentation Laboratory Recent Development
 Table 156. Sekisui Diagnostics Company Details
 Table 157. Sekisui Diagnostics Business Overview
 Table 158. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product
 Table 159. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2020-2025) & (US$ Million)
 Table 160. Sekisui Diagnostics Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Point of Care Diagnostics (POCD) Picture
 Figure 2. Global Point of Care Diagnostics (POCD) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Point of Care Diagnostics (POCD) Market Share by Type: 2024 VS 2031
 Figure 4. Blood Glucose Testing Features
 Figure 5. Infectious Diseases Testing Features
 Figure 6. Cardiac Markers Testing Features
 Figure 7. Coagulation Testing Features
 Figure 8. Pregnancy and Fertility Testing Features
 Figure 9. Blood Gas/Electrolytes Testing Features
 Figure 10. Tumor Markers Testing Features
 Figure 11. Urinalysis Testing Features
 Figure 12. Cholesterol Testing Features
 Figure 13. Global Point of Care Diagnostics (POCD) Market Size by Application (2020-2031) & (US$ Million)
 Figure 14. Global Point of Care Diagnostics (POCD) Market Share by Application: 2024 VS 2031
 Figure 15. Clinics Case Studies
 Figure 16. Hospitals Case Studies
 Figure 17. Assisted Living Healthcare Facilities Case Studies
 Figure 18. Laboratory Case Studies
 Figure 19. Point of Care Diagnostics (POCD) Report Years Considered
 Figure 20. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 21. Global Point of Care Diagnostics (POCD) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Region: 2024 VS 2031
 Figure 23. Global Point of Care Diagnostics (POCD) Market Share by Players in 2024
 Figure 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Diagnostics (POCD) as of 2024)
 Figure 25. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2024
 Figure 26. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. North America Point of Care Diagnostics (POCD) Market Share by Country (2020-2031)
 Figure 28. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Point of Care Diagnostics (POCD) Market Share by Country (2020-2031)
 Figure 32. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Nordic Countries Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Region (2020-2031)
 Figure 40. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Point of Care Diagnostics (POCD) Market Share by Country (2020-2031)
 Figure 48. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Country (2020-2031)
 Figure 52. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. UAE Point of Care Diagnostics (POCD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Alere Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 56. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 57. Abbott Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 58. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 59. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 60. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 61. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 62. Bayer Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 63. Beckman Coulter Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 64. Nipro Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 65. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 66. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 67. BioMerieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 68. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 69. Helena Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 70. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 71. Accriva Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 72. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 73. Chembio Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 74. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 75. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 76. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2020-2025)
 Figure 77. Bottom-up and Top-down Approaches for This Report
 Figure 78. Data Triangulation
 Figure 79. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Polymerase Chain Reaction for Point of Care Diagnostics Market
Rapid Point of Care PoC Diagnostics Market
Infectious Disease Point of Care Diagnostics Market
Point of Care Infectious Disease Diagnostics Testing Market
Point of care Infectious Disease Diagnostics Market
Cardiology Point of Care Diagnostics Market
Cartridge Based Point of Care Diagnostics System Market
Point of Care Coagulation Testing Market
Point of Care Testing for Infectious Disease Market
Point of Care Testing Market
DNA Testing Diagnostics Market
Mycoplasma Diagnostics Market
Veterinary Point of Care Diagnostics Market
 
 
 
 
 
 
 

RELATED REPORTS

Global Radiation Therapy Contouring Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Q19843
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global AI-Powered Gait & Mobility Analytics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33B19989
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Long-Term Post-Acute Care (LTPAC) Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16A20128
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Biliary and Pancreatic Drainage Stent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27T19786
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions